Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024
Toll free ( |
1-833-316-0561 |
International ( |
1-412-317-0690 |
069-22221534 | |
1-80-9212373 | |
Access Code | Please reference the “Lifeward Earnings Call” |
The conference call will be webcast live and the webcast can be accessed through a link on the Company’s website at GoLifeward.com in the "Investors" section, or through the following link: https://edge.media-server.com/mmc/p/3pun37to/. An archived webcast will also be available on the company's website.
About Lifeward
Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity systems, the ReStore Exo-Suit, and the MyoCycle
Founded in 2001, Lifeward has operations in the United States, Israel, and Germany. For more information on the Lifeward mission and product portfolio, please visit GoLifeward.com.
ReWalk®, ReStore® and Alter G® are registered trademarks of
Lifeward Media Relations:
E: media@golifeward.com
Lifeward Investor Contact:
Chief Financial Officer
Lifeward
E: ir@golifeward.com
Source: ReWalk Robotics Ltd.